UPDATE 1-Arthritis, lupus and asthma data a shot in arm for AstraZeneca – Reuters


Yahoo News

UPDATE 1-Arthritis, lupus and asthma data a shot in arm for AstraZeneca
Reuters
Benralizumab and tralokinumab both showed improvements in control of asthma in patients with specific, severe forms of the breathing disorder. All the drugs are being developed by MedImmune, the U.S.-based biotech company acquired by AstraZeneca in …
Arthritis, lupus and asthma data a shot in arm for AstraZenecaYahoo News
AstraZeneca: Mavrilimumab Produces Rapid Improvement In Signs, Symptoms Wall Street Journal
AstraZeneca Says MedImmune Phase II Trials Data PositiveLondon South East

all 8 news articles »

View full post on asthma – Google News